Article
*Correspondence: jbrenchl@mail.nih.gov
http://dx.doi.org/10.1016/j.immuni.2014.08.014
SUMMARY Among CD4+ T cells, three large populations exist: naive CD4+
T cells, memory CD4+ T cells, and terminally differentiated mem-
The viral accessory protein Vpx, expressed by certain ory CD4+ T cells (Brenchley et al., 2004a). While all three subsets
simian and human immunodeficiency viruses (SIVs are infected by the virus in vivo, they do not populate all anatom-
and HIVs), is thought to improve viral infectivity of ical sites equally (Brenchley et al., 2004b) and are not equally
myeloid cells. We infected 35 Asian macaques infected (Brenchley et al., 2004a), with memory CD4+ T cells
and African green monkeys with viruses that do or residing within the gastrointestinal (GI) tract infected most
frequently (Brenchley et al., 2004b; Mattapallil et al., 2005). Mem-
do not express Vpx and examined viral targeting of
ory CD4+ T cells are thought to live for decades (Combadiere
cells in vivo. While lack of Vpx expression affected
et al., 2004) and thus represent a very long-lived population of
viral dynamics in vivo, with decreased viral loads target cells for the virus. Myeloid cells have also been suggested
and infection of CD4+ T cells, Vpx expression had to be an important target cell population for HIV/SIV (Hirsch et al.,
no detectable effect on infectivity of myeloid cells. 1998; Igarashi et al., 2001; Koppensteiner et al., 2012; Orenstein
Moreover, viral DNA was observed only within et al., 1997) and although there has been some debate related to
myeloid cells in tissues not massively depleted of their longevity, it is generally thought their half life is approxi-
CD4+ T cells. Myeloid cells containing viral DNA also mately 12 months (Gonzalez-Mejia and Doseff, 2009; van Furth,
showed evidence of T cell phagocytosis in vivo, sug- 1989), with the possible exception of brain microglia cells (Greter
gesting that their viral DNA may be attributed to and Merad, 2013). However, recent findings that macrophages
phagocytosis of SIV-infected T cells. These data sug- are capable of proliferation in vivo suggest that tissue macro-
phages may, indeed, have a more limited life span (Jenkins
gest that myeloid cells are not a major source of SIV
et al., 2011; Robbins et al., 2013).
in vivo, irrespective of Vpx expression.
In fact, one factor that influences the ability of the virus to infect
individual cells is the proliferative capacity of the target cells.
INTRODUCTION Indeed, cells that are actively dividing are more prone to infection
in vivo than resting cells (Alexaki et al., 2008). One explanation for
Human immunodeficiency viruses (HIVs) and simian immuno- limited infectivity of resting cells, compared to activated and
deficiency viruses (SIVs) infect humans and nonhuman pri- dividing cells, is low intracellular concentrations of nucleotides
mates and these viruses persist for the life of the host. The within resting cells (Goldstone et al., 2011). In resting cells, nucle-
ability of HIV and SIV to maintain life-long infections is thought otides are hydrolyzed by the host protein SAM domain and
to depend on the ability of these viruses to latently infect long- HD domain-containing protein 1 (SAMHD1) (Goldstone et al.,
lived cells in vivo (Katlama et al., 2013). Therefore, understand- 2011). The activity of SAMHD1 is thought to involve its phosphor-
ing which cells are targeted by the virus is of critical ylation and is active in resting CD4+ T cells and myeloid cells, and
importance, as the life span of individual cells infected by the its expression and activity are thought to limit infection of these
virus will dictate the longevity of latent infection within the cells by HIV/SIV (Baldauf et al., 2012; Laguette et al., 2011).
host. The cells reported to be targeted by HIV and SIV in vivo Recent studies have implicated viral protein x (Vpx), a viral
are CD4+ T cells and myeloid cells (Alexaki et al., 2008). Neither accessory protein expressed by some strains of SIV and
CD4+ T cells nor myeloid cells represent a homogeneous pool by HIV-2, in binding to SAMHD1, leading to its proteasomal
of target cells. Instead, individual subsets of CD4+ T cells and degradation (Laguette et al., 2011). HIV-2 and SIVs used to
myeloid cells are thought to be differentially infected by the experimentally infect Asian macaques originate from SIVsmm,
virus in vivo. which is a virus that naturally infects sooty mangabeys in western
Immunity 41, 493502, September 18, 2014 2014 Elsevier Inc. 493
Immunity
Vpx Expression and Viral DNA in Macrophages
494 Immunity 41, 493502, September 18, 2014 2014 Elsevier Inc.
Immunity
Vpx Expression and Viral DNA in Macrophages
Immunity 41, 493502, September 18, 2014 2014 Elsevier Inc. 495
Immunity
Vpx Expression and Viral DNA in Macrophages
496 Immunity 41, 493502, September 18, 2014 2014 Elsevier Inc.
Immunity
Vpx Expression and Viral DNA in Macrophages
Immunity 41, 493502, September 18, 2014 2014 Elsevier Inc. 497
Immunity
Vpx Expression and Viral DNA in Macrophages
498 Immunity 41, 493502, September 18, 2014 2014 Elsevier Inc.
Immunity
Vpx Expression and Viral DNA in Macrophages
EXPERIMENTAL PROCEDURES
Subjects
To characterize and determine the cellular targets
for SIV in vivo, we studied tissues from a diverse
cohort of SIVagm-infected African green monkeys
and SIV-uninfected and -infected RM and PTM.
Tissues were obtained at necropsy from 22 rhesus
macaques (Macaca mulatta), 8 pigtail macaques
G (Macaca nemestrina), and 5 African green monkeys
(Chlorocebus pygerythrus) at a variety of times
after infection with SIVmac239, SIVmac239DVpx,
SIVsmE543, or SIVagm. Animals with simian AIDS
were diagnosed by opportunistic infections, lym-
phomas, or greater than 15% body mass weight
loss. Animals were housed and cared in accor-
dance with American Association for Accreditation
of Laboratory Animal Care standards in AAALAC-
accredited facilities, and all animal procedures
were performed according to the protocol
LMM12 approved by the Institutional Animal Care
and Use Committees of the National Institute of
Allergy and Infectious Diseases (Table 1). Mono-
cytes and lymphocytes from five healthy humans
that viral RNA and DNA within myeloid cells can be attributed to were obtained by the NIH blood bank. The subjects all gave informed consent
clearance of virally infected cells and immune complexes and in compliance with the NIH institutional review board.
not bone fide SIV infection of myeloid cells in vivo. Flow Cytometry
In summary, our findings suggest that the frequencies of The SIV infection frequency of naive, CD28+ memory, and CD28 memory
myeloid cells that contain viral DNA within certain anatomical CD4+ T cells and myeloid cells was determined by flow cytometrically sorting
sites of SIV-infected animals are not influenced by viral expres- each subset. Naive CD4+ T cells were defined as live, CD45+CD3+CD4+
sion of Vpx. Rather, viral DNA within myeloid cells in the tissues CD28+CD95 lymphocytes; CD28+ memory CD4+ T cells were defined
as live, CD45+CD3+CD4+CD28+CD95+ lymphocytes; CD28 memory CD4+
we studied may be attributed to phagocytosis of infected CD4+
T cells were defined as live, CD45+CD3+CD4+CD28CD95+/ lymphocytes;
T cells. This finding, in turn, strongly suggests that myeloid cells
myeloid cells were defined as live, CD45+CD3CD20NKG2AHLA-DR+.
may not represent a significant source of infected cells in vivo Cells were then stained with the live dead exclusion dye Aqua blue (Invitrogen),
and that therapeutic interventions aimed at stimulating latent then with antibodies to CD3 (clone SP34-2, BD Pharmingen), CD4 (clone L200,
virus should target CD4+ T cells. BD Pharmingen), CD95 (clone DX2, BD Pharmingen), CD28 (clone CD28.2,
Immunity 41, 493502, September 18, 2014 2014 Elsevier Inc. 499
Immunity
Vpx Expression and Viral DNA in Macrophages
500 Immunity 41, 493502, September 18, 2014 2014 Elsevier Inc.
Immunity
Vpx Expression and Viral DNA in Macrophages
sequenced by Eurofins MWG (Operon). Sequence analysis was performed expectations, and application to reverse engineering of vaccines for AIDS.
using Gene Codes Sequencher v.5.1. J. Med. Primatol. 34, 303312.
Combadiere, B., Boissonnas, A., Carcelain, G., Lefranc, E., Samri, A., Bricaire,
Plasma Viral Loads F., Debre, P., and Autran, B. (2004). Distinct time effects of vaccination on
Plasma samples were analyzed for SIV RNA using a fluorescent resonance en- long-term proliferative and IFN-gamma-producing T cell memory to smallpox
ergy transfer probe-based real-time RT-PCR (TaqMan) assay that provides a in humans. J. Exp. Med. 199, 15851593.
threshold sensitivity of 10 copy Eq/ml, as previously described (Cline et al.,
Cribier, A., Descours, B., Valadao, A.L., Laguette, N., and Benkirane, M.
2005). All PCR reactions were run on ABI Prism 7700 Sequence Detection Sys-
(2013). Phosphorylation of SAMHD1 by cyclin A2/CDK1 regulates its restric-
tem and the fluorescent signal-based quantitation of viral RNA copy numbers
tion activity toward HIV-1. Cell Rep 3, 10361043.
in test samples was determined by ABI sequence detection software (Applied
Biosystems). Dai, L., Lidie, K.B., Chen, Q., Adelsberger, J.W., Zheng, X., Huang, D., Yang, J.,
Statistical analysis was performed using GraphPad Prism v.5 using the Lempicki, R.A., Rehman, T., Dewar, R.L., et al. (2013). IL-27 inhibits HIV-1
Mann-Whitney t test. infection in human macrophages by down-regulating host factor SPTBN1 dur-
ing monocyte to macrophage differentiation. J. Exp. Med. 210, 517534.
SUPPLEMENTAL INFORMATION Dang, Q., Whitted, S., Goeken, R.M., Brenchley, J.M., Matsuda, K., Brown,
C.R., Lafont, B.A., Starost, M.F., Iyengar, R., Plishka, R.J., et al. (2012).
Supplemental Information includes two figures and can be found with this Development of neurological disease is associated with increased immune
article online at http://dx.doi.org/10.1016/j.immuni.2014.08.014. activation in simian immunodeficiency virus-infected macaques. J. Virol. 86,
1379513799.
ACKNOWLEDGMENTS Descours, B., Cribier, A., Chable-Bessia, C., Ayinde, D., Rice, G., Crow,
Y., Yatim, A., Schwartz, O., Laguette, N., and Benkirane, M. (2012).
We would like to acknowledge H. Cronise, J. Swerczek, R. Herbert, and all the SAMHD1 restricts HIV-1 reverse transcription in quiescent CD4(+) T-cells.
veterinary staff at the NIH animal center. We would like to thank CLIC/BBC for Retrovirology 9, 87.
advice and helpful discussions. Funding for this study was provided in part by
Finzi, D., Blankson, J., Siliciano, J.D., Margolick, J.B., Chadwick, K., Pierson,
the Division of Intramural Research/NIAID/NIH. The content of this publication
T., Smith, K., Lisziewicz, J., Lori, F., Flexner, C., et al. (1999). Latent infection of
does not necessarily reflect the views or policies of DHHS, nor does the
CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in
mention of trade names, commercial products, or organizations imply
patients on effective combination therapy. Nat. Med. 5, 512517.
endorsement by the US Government.
Fregoso, O.I., Ahn, J., Wang, C., Mehrens, J., Skowronski, J., and Emerman,
Received: March 26, 2014 M. (2013). Evolutionary toggling of Vpx/Vpr specificity results in divergent
Accepted: August 25, 2014 recognition of the restriction factor SAMHD1. PLoS Pathog. 9, e1003496.
Published: September 18, 2014 Gibbs, J.S., Lackner, A.A., Lang, S.M., Simon, M.A., Sehgal, P.K., Daniel,
M.D., and Desrosiers, R.C. (1995). Progression to AIDS in the absence of a
REFERENCES gene for vpr or vpx. J. Virol. 69, 23782383.
Goldstone, D.C., Ennis-Adeniran, V., Hedden, J.J., Groom, H.C., Rice, G.I.,
Alexaki, A., Liu, Y., and Wigdahl, B. (2008). Cellular reservoirs of HIV-1 and their
Christodoulou, E., Walker, P.A., Kelly, G., Haire, L.F., Yap, M.W., et al.
role in viral persistence. Curr. HIV Res. 6, 388400.
(2011). HIV-1 restriction factor SAMHD1 is a deoxynucleoside triphosphate
Baldauf, H.M., Pan, X., Erikson, E., Schmidt, S., Daddacha, W., Burggraf, triphosphohydrolase. Nature 480, 379382.
M., Schenkova, K., Ambiel, I., Wabnitz, G., Gramberg, T., et al. (2012).
Gonzalez-Mejia, M.E., and Doseff, A.I. (2009). Regulation of monocytes and
SAMHD1 restricts HIV-1 infection in resting CD4(+) T cells. Nat. Med. 18,
macrophages cell fate. Front Biosci (Landmark Ed) 14, 24132431.
16821687.
Berger, A., Sommer, A.F., Zwarg, J., Hamdorf, M., Welzel, K., Esly, N., Panitz, Gonzalez-Perez, M.P., OConnell, O., Lin, R., Sullivan, W.M., Bell, J.,
S., Reuter, A., Ramos, I., Jatiani, A., et al. (2011). SAMHD1-deficient CD14+ Simmonds, P., and Clapham, P.R. (2012). Independent evolution of macro-
cells from individuals with Aicardi-Goutieres syndrome are highly susceptible phage-tropism and increased charge between HIV-1 R5 envelopes present
to HIV-1 infection. PLoS Pathog. 7, e1002425. in brain and immune tissue. Retrovirology 9, 20.
Berger, G., Turpin, J., Cordeil, S., Tartour, K., Nguyen, X.N., Mahieux, R., and Greter, M., and Merad, M. (2013). Regulation of microglia development and
Cimarelli, A. (2012). Functional analysis of the relationship between Vpx and homeostasis. Glia 61, 121127.
the restriction factor SAMHD1. J. Biol. Chem. 287, 4121041217. Heeregrave, E.J., Geels, M.J., Brenchley, J.M., Baan, E., Ambrozak, D.R., van
Bloch, N., OBrien, M., Norton, T.D., Polsky, S.B., Bhardwaj, N., and Landau, der Sluis, R.M., Bennemeer, R., Douek, D.C., Goudsmit, J., Pollakis, G., et al.
N.R. (2014). HIV type 1 infection of plasmacytoid and myeloid dendritic cells is (2009). Lack of in vivo compartmentalization among HIV-1 infected nave and
restricted by high levels of SAMHD1 and cannot be counteracted by Vpx. AIDS memory CD4+ T cell subsets. Virology 393, 2432.
Res. Hum. Retroviruses 30, 195203. Hirsch, V.M., Sharkey, M.E., Brown, C.R., Brichacek, B., Goldstein, S.,
Brenchley, J.M., Hill, B.J., Ambrozak, D.R., Price, D.A., Guenaga, F.J., Wakefield, J., Byrum, R., Elkins, W.R., Hahn, B.H., Lifson, J.D., and
Casazza, J.P., Kuruppu, J., Yazdani, J., Migueles, S.A., Connors, M., et al. Stevenson, M. (1998). Vpx is required for dissemination and pathogenesis of
(2004a). T-cell subsets that harbor human immunodeficiency virus (HIV) in vivo: SIV(SM) PBj: evidence of macrophage-dependent viral amplification. Nat.
implications for HIV pathogenesis. J. Virol. 78, 11601168. Med. 4, 14011408.
Brenchley, J.M., Schacker, T.W., Ruff, L.E., Price, D.A., Taylor, J.H., Beilman, Hrecka, K., Hao, C., Gierszewska, M., Swanson, S.K., Kesik-Brodacka, M.,
G.J., Nguyen, P.L., Khoruts, A., Larson, M., Haase, A.T., and Douek, D.C. Srivastava, S., Florens, L., Washburn, M.P., and Skowronski, J. (2011). Vpx re-
(2004b). CD4+ T cell depletion during all stages of HIV disease occurs predom- lieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1
inantly in the gastrointestinal tract. J. Exp. Med. 200, 749759. protein. Nature 474, 658661.
Burdo, T.H., Soulas, C., Orzechowski, K., Button, J., Krishnan, A., Sugimoto, Igarashi, T., Brown, C.R., Endo, Y., Buckler-White, A., Plishka, R.,
C., Alvarez, X., Kuroda, M.J., and Williams, K.C. (2010). Increased monocyte Bischofberger, N., Hirsch, V., and Martin, M.A. (2001). Macrophage are the
turnover from bone marrow correlates with severity of SIV encephalitis and principal reservoir and sustain high virus loads in rhesus macaques after the
CD163 levels in plasma. PLoS Pathog. 6, e1000842. depletion of CD4+ T cells by a highly pathogenic simian immunodeficiency
Cline, A.N., Bess, J.W., Piatak, M., Jr., and Lifson, J.D. (2005). Highly sensitive virus/HIV type 1 chimera (SHIV): Implications for HIV-1 infections of humans.
SIV plasma viral load assay: practical considerations, realistic performance Proc. Natl. Acad. Sci. USA 98, 658663.
Immunity 41, 493502, September 18, 2014 2014 Elsevier Inc. 501
Immunity
Vpx Expression and Viral DNA in Macrophages
Igarashi, T., Imamichi, H., Brown, C.R., Hirsch, V.M., and Martin, M.A. (2003). progressive simian immunodeficiency virus infection. J. Exp. Med. 200,
The emergence and characterization of macrophage-tropic SIV/HIV chimeric 12991314.
viruses (SHIVs) present in CD4+ T cell-depleted rhesus monkeys. J. Leukoc. Robbins, C.S., Hilgendorf, I., Weber, G.F., Theurl, I., Iwamoto, Y., Figueiredo,
Biol. 74, 772780. J.L., Gorbatov, R., Sukhova, G.K., Gerhardt, L.M., Smyth, D., et al. (2013).
Jenkins, S.J., Ruckerl, D., Cook, P.C., Jones, L.H., Finkelman, F.D., van Local proliferation dominates lesional macrophage accumulation in athero-
Rooijen, N., MacDonald, A.S., and Allen, J.E. (2011). Local macrophage prolif- sclerosis. Nat. Med. 19, 11661172.
eration, rather than recruitment from the blood, is a signature of TH2 inflamma-
Siliciano, J.D., and Siliciano, R.F. (2013). HIV-1 eradication strategies: design
tion. Science 332, 12841288.
and assessment. Curr Opin HIV AIDS 8, 318325.
Katlama, C., Deeks, S.G., Autran, B., Martinez-Picado, J., van Lunzen, J.,
Rouzioux, C., Miller, M., Vella, S., Schmitz, J.E., Ahlers, J., et al. (2013). Smith, P.D., Meng, G., Salazar-Gonzalez, J.F., and Shaw, G.M. (2003).
Barriers to a cure for HIV: new ways to target and eradicate HIV-1 reservoirs. Macrophage HIV-1 infection and the gastrointestinal tract reservoir.
Lancet 381, 21092117. J. Leukoc. Biol. 74, 642649.
Koenig, S., Gendelman, H.E., Orenstein, J.M., Dal Canto, M.C., Pezeshkpour, Spits, H. (2002). Development of alphabeta T cells in the human thymus. Nat.
G.H., Yungbluth, M., Janotta, F., Aksamit, A., Martin, M.A., and Fauci, A.S. Rev. Immunol. 2, 760772.
(1986). Detection of AIDS virus in macrophages in brain tissue from AIDS Thompson, K.A., Cherry, C.L., Bell, J.E., and McLean, C.A. (2011). Brain cell
patients with encephalopathy. Science 233, 10891093. reservoirs of latent virus in presymptomatic HIV-infected individuals. Am. J.
Koppensteiner, H., Brack-Werner, R., and Schindler, M. (2012). Macrophages Pathol. 179, 16231629.
and their relevance in human immunodeficiency virus type I infection. van Furth, R. (1989). Origin and turnover of monocytes and macrophages.
Retrovirology 9, 82. Curr. Top. Pathol. 79, 125150.
Laguette, N., Sobhian, B., Casartelli, N., Ringeard, M., Chable-Bessia, C.,
Veazey, R.S., DeMaria, M., Chalifoux, L.V., Shvetz, D.E., Pauley, D.R., Knight,
Segeral, E., Yatim, A., Emiliani, S., Schwartz, O., and Benkirane, M. (2011).
H.L., Rosenzweig, M., Johnson, R.P., Desrosiers, R.C., and Lackner, A.A.
SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor
(1998). Gastrointestinal tract as a major site of CD4+ T cell depletion and viral
counteracted by Vpx. Nature 474, 654657.
replication in SIV infection. Science 280, 427431.
Margolis, D.M. (2011). Histone deacetylase inhibitors and HIV latency. Curr
Wang, T.H., Donaldson, Y.K., Brettle, R.P., Bell, J.E., and Simmonds, P.
Opin HIV AIDS 6, 2529.
(2001). Identification of shared populations of human immunodeficiency virus
Mattapallil, J.J., Douek, D.C., Hill, B., Nishimura, Y., Martin, M., and Roederer,
type 1 infecting microglia and tissue macrophages outside the central nervous
M. (2005). Massive infection and loss of memory CD4+ T cells in multiple
system. J. Virol. 75, 1168611699.
tissues during acute SIV infection. Nature 434, 10931097.
Westmoreland, S.V., Converse, A.P., Hrecka, K., Hurley, M., Knight, H., Piatak,
Orenstein, J.M., Fox, C., and Wahl, S.M. (1997). Macrophages as a source of
M., Lifson, J., Mansfield, K.G., Skowronski, J., and Desrosiers, R.C. (2014). SIV
HIV during opportunistic infections. Science 276, 18571861.
vpx is essential for macrophage infection but not for development of AIDS.
Ortiz, A.M., Klatt, N.R., Li, B., Yi, Y., Tabb, B., Hao, X.P., Sternberg, L., Lawson, PLoS ONE 9, e84463.
B., Carnathan, P.M., Cramer, E.M., et al. (2011). Depletion of CD4+ T cells
abrogates post-peak decline of viremia in SIV-infected rhesus macaques. Wu, F., Ourmanov, I., Kuwata, T., Goeken, R., Brown, C.R., Buckler-White, A.,
J. Clin. Invest. 121, 44334445. Iyengar, R., Plishka, R., Aoki, S.T., and Hirsch, V.M. (2012). Sequential evolu-
tion and escape from neutralization of simian immunodeficiency virus
Pauls, E., Jimenez, E., Ruiz, A., Permanyer, M., Ballana, E., Costa, H.,
SIVsmE660 clones in rhesus macaques. J. Virol. 86, 88358847.
Nascimiento, R., Parkhouse, R.M., Pena, R., Riveiro-Munoz, E., et al. (2013).
Restriction of HIV-1 replication in primary macrophages by IL-12 and IL-18 Wynn, T.A., Chawla, A., and Pollard, J.W. (2013). Macrophage biology in
through the upregulation of SAMHD1. J. Immunol. 190, 47364741. development, homeostasis and disease. Nature 496, 445455.
Picker, L.J., Hagen, S.I., Lum, R., Reed-Inderbitzin, E.F., Daly, L.M., Sylwester, Yao, R., and Schneider, E. (2007). Detection of B- and T-cell-specific gene re-
A.W., Walker, J.M., Siess, D.C., Piatak, M., Jr., Wang, C., et al. (2004). arrangements in 13 cell lines and 50 clinical specimens using the BIOMED-2
Insufficient production and tissue delivery of CD4+ memory T cells in rapidly and the original InVivoScribe primers. Leuk. Lymphoma 48, 837840.
502 Immunity 41, 493502, September 18, 2014 2014 Elsevier Inc.